Literature DB >> 28387847

Does atrial fibrillation cause cognitive decline and dementia?

Joanna Dietzel1, Karl Georg Haeusler1,2, Matthias Endres1,2,3,4,5,6.   

Abstract

Atrial fibrillation (AF) and dementia are both frequent diseases with substantial socioeconomic impact. While AF has been associated with cognitive dysfunction and dementia, we currently lack an exact understanding of the complex association between AF and cognitive decline. Based on an extended literature search we summarize key publications focusing on AF-related cognitive decline and dementia. Moreover, ongoing trials and potential therapeutic implications are discussed. While further prospective studies using a standardized definition of AF and cognitive decline are urgently needed, growing evidence supports the hypothesis that AF is an independent risk factor for cognitive decline and dementia in general and for Alzheimer's disease in particular. In addition to AF-related ischaemic stroke, white matter damage and systemic inflammation are candidate pathomechanisms and therefore a potential target for prevention of cognitive decline. Whether individualized best-medical therapy of AF holds the promise of preventing cognitive decline should be tested in randomized trials.

Entities:  

Mesh:

Year:  2018        PMID: 28387847     DOI: 10.1093/europace/eux031

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  27 in total

1.  Catheter Ablation and Cognitive Impairment in Atrial Fibrillation: Another Hit or a Silver Bullet?

Authors:  Lindsey Rosman; Matthew M Burg; Rachel Lampert
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-07-01

2.  Cognitive Screening in Geriatric Patients with Atrial Fibrillation Evaluated for Falls.

Authors:  Zwart L A R; Germans T; Simsek S; Hemels M E W; Ruiter J H; Jansen R W M M
Journal:  J Atr Fibrillation       Date:  2020-04-30

3.  Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis.

Authors:  Igor Diemberger; Stefano Fumagalli; Anna Maria Mazzone; Ameet Bakhai; Paul Egbert Reimitz; Ladislav Pecen; Marius Constantin Manu; José Antonio Gordillo de Souza; Paulus Kirchhof; Raffaele De Caterina
Journal:  Europace       Date:  2022-10-13       Impact factor: 5.486

4.  Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion.

Authors:  Marianna Gardarsdottir; Sigurdur Sigurdsson; Thor Aspelund; Hrafnhildur Rokita; Lenore J Launer; Vilmundur Gudnason; David O Arnar
Journal:  Europace       Date:  2018-08-01       Impact factor: 5.214

5.  Improved brain perfusion after electrical cardioversion of atrial fibrillation.

Authors:  Marianna Gardarsdottir; Sigurdur Sigurdsson; Thor Aspelund; Valdis Anna Gardarsdottir; Lars Forsberg; Vilmundur Gudnason; David O Arnar
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

6.  Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population-Based Cohort Study.

Authors:  Jin-Yi Hsu; Peter Pin-Sung Liu; An-Bang Liu; Shu-Man Lin; Huei-Kai Huang; Ching-Hui Loh
Journal:  J Am Heart Assoc       Date:  2021-02-15       Impact factor: 5.501

7.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?

Authors:  Nikolaos Dagres; Tze-Fan Chao; Guilherme Fenelon; Luis Aguinaga; Daniel Benhayon; Emelia J Benjamin; T Jared Bunch; Lin Yee Chen; Shih-Ann Chen; Francisco Darrieux; Angelo de Paola; Laurent Fauchier; Andreas Goette; Jonathan Kalman; Lalit Kalra; Young-Hoon Kim; Deirdre A Lane; Gregory Y H Lip; Steven A Lubitz; Manlio F Márquez; Tatjana Potpara; Domingo Luis Pozzer; Jeremy N Ruskin; Irina Savelieva; Wee Siong Teo; Hung-Fat Tse; Atul Verma; Shu Zhang; Mina K Chung; William-Fernando Bautista-Vargas; Chern-En Chiang; Alejandro Cuesta; Gheorghe-Andrei Dan; David S Frankel; Yutao Guo; Robert Hatala; Young Soo Lee; Yuji Murakawa; Cara N Pellegrini; Claudio Pinho; David J Milan; Daniel P Morin; Elenir Nadalin; George Ntaios; Mukund A Prabhu; Marco Proietti; Lena Rivard; Mariana Valentino; Alena Shantsila
Journal:  J Arrhythm       Date:  2018-03-23

8.  Poor oral health conditions and cognitive decline: Studies in humans and rats.

Authors:  Shuang Zhang; Fengchun Yang; Zezheng Wang; Xueshen Qian; Yan Ji; Ling Gong; Song Ge; Fuhua Yan
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

9.  Variation in VKORC1 Is Associated with Vascular Dementia.

Authors:  Jure Mur; Daniel L McCartney; Daniel I Chasman; Peter M Visscher; Graciela Muniz-Terrera; Simon R Cox; Tom C Russ; Riccardo E Marioni
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

10.  Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies.

Authors:  Chi Zhang; Zhi-Chun Gu; Long Shen; Mang-Mang Pan; Yi-Dan Yan; Jun Pu; Xiao-Yan Liu; Hou-Wen Lin
Journal:  Front Aging Neurosci       Date:  2018-10-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.